Company Overview:
Cipla is engaged in the Business of Pharmaceuticals. Cipla has a diversified product portfolio of 1,500+ products in 50+ dosage forms and 65 therapeutic categories.
Financial Results:
Cipla reported Total revenue for Q4FY25 of ₹ 7,019 Crore up from ₹14,932 Crore in Q4FY24, a rise of 9% y-o-y.
Total Expense for Q4FY25 of ₹5,514 Crore up from ₹5,153 Crore in Q4FY24, a rise of 7% y-o-y.
Net Profit of ₹1,214 Crore up 30% from ₹932 Crore in Q4FY24.
Earnings per Share is ₹15.13, up 30% from ₹11.63 in Q4FY24.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,